Clinical Trial

Metabolic Imaging of Neurological Disease

Study acronym: MIND
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Multiple Sclerosis is a chronic condition that shows changes in the way that the brain consumes sugar. It is also known that there are a number of metabolic and inflammatory sequelae following a transient ischemic attack/stroke (hereby referred to collectively as 'stroke'). This study will use a powerful new technology ('hyperpolarised magnetic resonance imaging') to detect these changes in the brains of people with multiple sclerosis and Clinically Isolated Syndrome (CIS) or following a stroke when compared to a group of healthy volunteers. It will be undertaken at the University of Oxford, and each participant will undergo up to 4 scans over the course of three years.
Trial Details
NCT Number NCT06900244
Lead Sponsor University of Oxford
Conditions Multiple Sclerosis
Enrollment 250 participants
Start Date 2021-07-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-28